Press release
Pneumococcal Vaccine Market is Anticipated to Reach USD 13,384.28 million by 2032
The global pneumococcal vaccine market has emerged as a critical pillar within the preventive healthcare and immunization ecosystem, driven by the persistent burden of pneumococcal diseases such as pneumonia, meningitis, and bacteremia across both developed and developing regions. In 2024, the market was valued at USD 8,787.6 million and is anticipated to reach USD 13,384.28 million by 2032, expanding at a compound annual growth rate (CAGR) of 5.4% during the forecast period.
Pneumococcal infections remain a leading cause of morbidity and mortality, particularly among infants, young children, elderly populations, and immunocompromised individuals. The increasing adoption of routine childhood immunization programs, combined with expanding adult and geriatric vaccination recommendations, has significantly strengthened global demand for pneumococcal vaccines. In addition, the introduction of higher-valent conjugate vaccines, growing public health funding, and rising awareness of vaccine-preventable diseases continue to reinforce market expansion.
Browse the full report at https://www.credenceresearch.com/report/pneumococcal-vaccines-market/
Disease Burden and Public Health Importance
Streptococcus pneumoniae is responsible for a wide spectrum of invasive and non-invasive diseases. Despite improvements in antibiotic therapy, vaccine-based prevention remains the most effective long-term strategy due to increasing antimicrobial resistance. Pneumococcal vaccines have demonstrated strong efficacy in reducing disease incidence, hospitalization rates, and healthcare costs, particularly in pediatric and elderly populations.
Global health agencies and national immunization programs have prioritized pneumococcal vaccination as a core component of preventive healthcare. This has resulted in sustained procurement volumes through government-funded immunization initiatives, especially in emerging economies across Asia Pacific, Latin America, and Africa.
Market Segmentation Analysis
By Product
The pneumococcal vaccine market is segmented into Pneumosil (PCV10), Pneumovax 23 (PPSV23), Prevnar 13 (PCV13), Prevnar 20 (PCV20), Synflorix (PCV10), Vaxneuvance (PCV15), and other products.
Prevnar 13 (PCV13) has historically dominated global revenues due to its broad serotype coverage, strong clinical efficacy, and early adoption across national immunization programs. However, the market is witnessing a gradual shift toward higher-valent vaccines such as PCV15 and PCV20, which offer expanded protection against additional pneumococcal serotypes.
Pneumovax 23 (PPSV23) continues to play a critical role in adult and elderly vaccination, particularly for high-risk populations. Meanwhile, cost-effective alternatives such as Pneumosil and Synflorix are gaining traction in low- and middle-income countries due to affordability and support from global health organizations.
By Vaccine Type
Based on vaccine type, the market is classified into pneumococcal conjugate vaccines (PCV) and pneumococcal polysaccharide vaccines (PPSV).
Pneumococcal conjugate vaccines (PCVs) account for the majority market share, driven by their superior immunogenicity, long-term immune memory, and effectiveness in infants and young children. PCVs have become the preferred option in routine pediatric immunization schedules worldwide.
Pneumococcal polysaccharide vaccines (PPSVs), while limited in inducing immune memory, remain widely used in adult and geriatric populations, particularly for broader serotype coverage. Their role remains complementary, especially in booster and risk-based vaccination strategies.
Get Free PDF Sample Request: https://www.credenceresearch.com/report/pneumococcal-vaccines-market/#request_sample
By Age Group
The market is segmented into infants and children (0-5 years), adults (18-64 years), and elderly (65+ years).
The infants and children segment represents the largest revenue share, supported by mandatory childhood vaccination programs and strong government procurement. Early-life immunization significantly reduces invasive pneumococcal disease incidence, making this segment the backbone of market demand.
The elderly population segment is projected to exhibit the fastest growth during the forecast period. Aging demographics, rising prevalence of chronic diseases, and expanded adult vaccination recommendations are accelerating uptake in this age group.
The adult segment (18-64 years) also contributes steadily, particularly among individuals with comorbidities, occupational exposure risks, and compromised immune systems.
Regional Analysis
North America
North America holds a significant share of the global pneumococcal vaccine market, led by the United States, followed by Canada and Mexico. High awareness levels, strong healthcare infrastructure, and favorable reimbursement frameworks support widespread vaccine adoption. The region has been at the forefront of introducing next-generation conjugate vaccines, driving value-based growth.
Europe
Europe represents a mature yet steadily growing market, with key contributions from Germany, France, the U.K., Italy, and Spain. Well-established national immunization programs and consistent public health funding underpin demand. The region is witnessing increased uptake of higher-valent PCVs and adult booster programs.
Asia Pacific
Asia Pacific is the fastest-growing regional market, driven by large birth cohorts, improving healthcare access, and expanding government immunization coverage across China, India, Japan, South Korea, and Southeast Asia. Local manufacturing, international partnerships, and support from global health alliances are improving vaccine affordability and availability in this region.
Latin America
Latin America, led by Brazil and Argentina, continues to demonstrate stable growth supported by public vaccination initiatives and regional procurement programs. Increasing awareness and healthcare investments are strengthening pneumococcal vaccine penetration across both pediatric and adult populations.
Middle East & Africa
The Middle East & Africa market is gradually expanding, with GCC countries and South Africa serving as key growth centers. Although vaccine coverage remains uneven, international funding support and government-led immunization strategies are improving market accessibility in underserved regions.
Browse the full report at https://www.credenceresearch.com/report/pneumococcal-vaccines-market/
Key Market Drivers
Several factors are driving sustained growth in the pneumococcal vaccine market:
Rising global burden of pneumococcal diseases
Expansion of routine childhood immunization programs
Growing elderly population and age-related vulnerability
Introduction of higher-valent conjugate vaccines
Increased government and NGO funding for vaccination initiatives
Together, these drivers reinforce long-term demand stability and market resilience.
Market Challenges
Despite strong growth fundamentals, the market faces certain challenges:
High development and manufacturing costs of conjugate vaccines
Cold-chain logistics complexities in low-income regions
Serotype replacement and evolving epidemiology
Vaccine hesitancy in certain populations
Addressing these challenges requires continued innovation, public education, and infrastructure investment.
Competitive Landscape and Key Player Analysis
The pneumococcal vaccine market is moderately consolidated, with a mix of multinational pharmaceutical companies and regional manufacturers actively competing across global markets.
Pfizer remains a market leader, driven by its Prevnar franchise and strong presence across developed and emerging markets. The company's focus on higher-valent conjugate vaccines strengthens its long-term competitive position.
Merck & Co. plays a key role through its polysaccharide vaccine portfolio, particularly in adult and elderly vaccination segments.
GlaxoSmithKline maintains a strong presence in pediatric immunization programs, especially across Europe and emerging markets, supported by its conjugate vaccine offerings.
Serum Institute of India is a major supplier to low- and middle-income countries, leveraging large-scale manufacturing capabilities and cost-efficient vaccine production.
Walvax Biotechnology and Beijing Minhai Biological Technology are strengthening China's domestic supply and regional exports.
Bio-Manguinhos/Fiocruz plays a vital role in Latin America through public-sector vaccine production and distribution.
Future Outlook
Looking ahead, the pneumococcal vaccine market is expected to maintain steady, value-driven growth through 2032. Continued innovation in vaccine valency, expanded adult immunization policies, and improved access in emerging markets will remain central to future expansion.
Strategic collaborations between governments, global health organizations, and manufacturers will be critical in addressing affordability and access challenges. As public health systems increasingly emphasize preventive care, pneumococcal vaccination will continue to represent a cornerstone of global disease prevention strategies.
In summary, the pneumococcal vaccine market presents a robust, long-term growth opportunity underpinned by strong epidemiological demand, expanding immunization coverage, and ongoing product innovation-positioning it as a vital segment within the global vaccines landscape.
Browse the full report at https://www.credenceresearch.com/report/pneumococcal-vaccines-market/
For Industry Report:
Static VAR Compensator Market : https://www.credenceresearch.com/report/static-var-compensator-market
Automotive Interior Component Market : https://www.credenceresearch.com/report/automotive-interior-component-market
Magnetic Geophysical Services Market: https://www.credenceresearch.com/report/magnetic-geophysical-services-market
Bed Monitoring System and Baby Monitoring System Market: https://www.credenceresearch.com/report/bed-monitoring-system-and-baby-monitoring-system-market
Social Listening Solutions Market :https://www.credenceresearch.com/report/social-listening-solutions-market
Contact US:
Credence Research Inc, Tower C-1105 , S 25, Akash Tower,
Vishal Nahar, Pimple Nilakh, Haveli,
Pune - 411027, India
India - +91 6232 49 3207
sales@credenceresearch.com
www.credenceresearch.com
About US:
Credence Research is a leading international provider of market intelligence and a key component in the due diligence process. We deliver high-quality, extensive, deep-dive reports that empower leaders and investors to make informed decisions and mitigate risks. Our strategic insights, based on extensive research frameworks and advanced data modeling, provide authoritative primary sources for evaluating market performance and potential across a wide range of industries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pneumococcal Vaccine Market is Anticipated to Reach USD 13,384.28 million by 2032 here
News-ID: 4365381 • Views: …
More Releases from Credence Research
RAIN RFID Solutions Market is Anticipated to Reach USD 4,810.7 million by 2032 | …
Market Overview
The global RAIN RFID Solutions Market has emerged as a critical enabler of digital transformation across retail, logistics, healthcare, transportation, and industrial ecosystems. RAIN RFID-a standardized, ultra-high frequency (UHF) passive RFID technology-allows enterprises to identify, locate, authenticate, and track items at scale with high accuracy and speed. As supply chains become more complex and data-driven, the demand for real-time item-level visibility continues to accelerate worldwide.
The RAIN RFID Solutions Market…
Hyaluronic Acid Market is Projected to Reach USD 19,272 million by 2032 | Creden …
Global Hyaluronic Acid Market: Size, Trends, Segmentation, Growth Drivers, and Forecast to 2032
The global hyaluronic acid market has emerged as one of the most dynamic segments within the broader biomaterials and life sciences industry, driven by expanding applications across pharmaceuticals, medical aesthetics, ophthalmology, and orthopedic care. In 2024, the market was valued at USD 10,718 million and is projected to reach USD 19,272 million by 2032, expanding at a compound…
Traction Equipment Market Size, Trends, Growth Analysis, and Forecast to 2032
Market Overview
The Traction Equipment Market has emerged as a critical backbone of modern electrified transportation and industrial mobility systems, supporting the global shift toward energy efficiency, electrification, and low-carbon infrastructure. Traction equipment encompasses a broad range of systems and components-including traction motors, converters, and transformers-that enable controlled power transmission for railways, electric vehicles, marine vessels, and heavy industrial equipment.
In 2018, the global traction equipment market was valued at USD 6,234.4…
Pickup Truck Market Size, Share, Analysis, Trends and Growth Forecast 2032
Pickup Truck Market: Size, Growth Outlook, and Strategic Analysis
The global pickup truck market represents a critical segment of the automotive industry, combining utility, durability, and evolving lifestyle appeal. Traditionally associated with commercial and industrial usage, pickup trucks have increasingly penetrated personal and recreational mobility segments, particularly in developed economies. The market has demonstrated consistent resilience despite economic cycles, driven by strong demand from construction, logistics, agriculture, and increasingly from urban…
More Releases for PCV
Automotive Positive Crankcase Ventilation PCV Valve Market Report 2025 To 2034
"PCV valves are critical for engine performance and emissions control-explore the growing demand within the automotive parts industry."
On March 7, 2025, Exactitude Consultancy., Ltd. Newly released a research report titled "Automotive Positive Crankcase Ventilation Pcv Valve Market". The automotive PCV valve market is growing as vehicle manufacturers continue to focus on reducing emissions and improving engine efficiency. The PCV valve plays a crucial role in the internal combustion engine by…
HGVC: Top Driver Academy for PCV & HGV Training
HGVC, a top driver training academy, provides driver risk assessment and PCV & HGV training.
When people desire to advance in their careers, they require training programmes to earn certificates that set them apart from other professionals. In the United Kingdom, HGVC is a leading driver training academy that provides standard training services. The driver training school has been in operation for years. They have well-trained and qualified instructors on their…
HGVC Provides HGV Skills Bootcamp for Businesses and PCV Training Courses
Through distinct and well-equipped training facilities and programmes, people who aspire to become top professionals in their field can grow and develop new skills. Those who want to become professional drivers must find an instructor or platform to train and prepare themselves for their license acquisition exams.
In the United Kingdom, HGVC is a leading driver academy providing professional licence acquisition programmes. The Driver Academy offers wide-ranging courses that provide drivers…
Unsung Hero of Engine Performance: Exploring the Function and Importance of Auto …
Positive crankcase ventilation (PCV) in the crankcase holds the motor oil in the vehicle and is located at the bottom of a vehicle engine. The automotive positive crankcase ventilation (PCV) framework lessens blow-by emissions from the motor. Moreover, about 20% of the all-out hydrocarbon (HC) emissions created by a vehicle are blown by discharges from gases that move beyond the cylinder rings and enter the crankcase. Also, the higher mileage…
PCV Automotive EVAP Systems Market Precise Outlook 2021- Delphi Technologies, Ea …
The report studies the Global PCV Automotive EVAP Systems Market with many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. The report offers valuable insight into the PCV Automotive EVAP Systems Market progress and approaches related to the market with an analysis of each region. The…
Automotive Positive Crankcase Ventilation Valve (PCV Valve) Market Size, Share, …
LP INFORMATION offers a latest published report on Automotive Positive Crankcase Ventilation Valve (PCV Valve) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Automotive Positive Crankcase Ventilation Valve (PCV Valve) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million…
